Model Building
Model Building is the systematic process of constructing a mathematical representation of pharmacokinetic behavior within a population by selecting structural, statistical, and variance components that best describe observed concentration-time data and inter-individual variability.
4.9K
Publications
300.2K
Citations
15.8K
Authors
3.8K
Institutions
Publications per year
2017–2026
1.4K
Variants
Pharmacokinetic Model Building
Parents
4.9K
A pharmacokinetic analysis program (multi) for microcomputer.
Kiyoshi Yamaoka, Yusuke Tanigawara, Terumichi Nakagawa et al. · Journal of Pharmacobio-Dynamics · 1981 · 2.5K citations · Full text
André DeLÉAN, Peter J. Munson, David Rodbard · American Journal of Physiology-Endocrinology and Metabolism · 1978 · 2.4K citations
1–5 of 4.9K
15.8K
University of California, San Francisco, United States
45 publications · 7.9K citations
33
h-index
26
h-index
25
h-index
25
h-index
24
h-index
1–5 of 15.8K
3.8K
University of California, San Francisco
San Francisco, United States
47 h-index
134 publications
20.9K citations

University of Manchester
Manchester, United Kingdom
42 h-index
238 publications
15.3K citations
Pfizer (United States)
New York, United States
39 h-index
234 publications
15.2K citations
Center for Drug Evaluation and Research
Silver Spring, United States
38 h-index
360 publications
33K citations
Roche (Switzerland)
Basel, Switzerland
38 h-index
187 publications
13.7K citations

Uppsala University
Uppsala, Sweden
38 h-index
263 publications
17.4K citations
Inserm
Paris, France
38 h-index
265 publications
13.5K citations
AstraZeneca (United Kingdom)
Cambridge, United Kingdom
35 h-index
140 publications
6.4K citations
1–8 of 3.8K
PSP · 168 publications · 11.1K citations
51
h-index
112 publications · 8.5K citations
48
h-index
101 publications · 10.2K citations
45
h-index
CPT · 86 publications · 6.2K citations
43
h-index
134 publications · 7.6K citations
41
h-index
1–5